NeuroOne CEO Joins As we speak’s Market To Talk about The Newest Remedies for Epilepsy

Featured13 hours ago4 Views

Today's Marketplace
As we speak’s Market

NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) —  As we speak’s Market (TMP) is proud to announce a featured interview with NeuroOne Medical Applied sciences Company (NASDAQ: NMTC) CEO Dave Rosa and Jessica Clark, DNP, RN, Dean of the Faculty of Nursing at Creighton College. The pair joined As we speak’s Market host Elizabeth Hart to debate the most recent therapies for epilepsy

The total interview may be considered on-line right here.

“Epilepsy is a neurological situation,” defined Dr. Clark. “Proper now we’re taking a look at about fifty million folks worldwide impacted by it. Epilepsy can have an effect on anybody at any time, and within the US right now, now we have over three million folks recognized with the situation.”

Dr. Clark went on to clarify to Hart that there are numerous remedy choices obtainable for folks with epilepsy right now, and most victims can handle their seizures nicely with prescription drugs. Nevertheless, roughly one-third of epilepsy sufferers don’t react nicely to present antiseizure drugs, which leaves roughly a million folks in want of different nonpharmaceutical types of remedy.

Mr. Rosa described this group of sufferers searching for non-drug choices for the administration of epilepsy as precisely the affected person inhabitants NeuroOne is addressing.

Addressing this essential want, NeuroOne has developed the OneRF™ ablation system, the primary and solely FDA 510(ok)-cleared machine able to each recording mind exercise and performing an RF ablation utilizing the identical machine. The system has three most important elements: an electrode that data and displays mind exercise whereas additionally performing an ablation, a temperature probe, and a radio frequency warmth era system

A key innovation of the machine is its proprietary temperature probe that ensures the ablation is carried out at secure temperatures.

“I actually imagine that the FDA cleared the system as rapidly as they did, which was solely 5 months as a result of we’re in a position to monitor the real-time temperature within the mind through the ablation course of,” stated Rosa

Rosa went on to clarify that one other distinctive characteristic of the system is that the electrodes may be left safely in place after the preliminary ablation procedures, so that ought to seizure exercise return, it’s a secure and simple course of for a neurosurgeon to return and carry out extra ablations within the focused areas earlier than the affected person is discharged from the hospital. He identified that the aim is for this to be a one-time process to be able to decrease the necessity to return for follow-up procedures.

“Previous to our expertise, a affected person must are available for one surgical process to have the electrodes positioned to determine the areas that might reply to ablation. They then would take away the gadgets, after which the affected person needed to schedule one other invasive surgical procedure to carry out the precise ablation, solely to be despatched residence with out the power to observe how profitable the process was. With our machine, it is one hospitalization. The ablation is completed, you’re monitored after with the identical gadgets, and if every part is again to regular, you go residence.”

Leave a reply

STEINEWS SOCIAL
  • Facebook38.5K
  • X Network32.1K
  • Behance56.2K
  • Instagram18.9K

Stay Informed With the Latest & Most Important News

I consent to receive newsletter via email. For further information, please review our Privacy Policy

Advertisement

Loading Next Post...
Follow
Sidebar Search Trending
Popular Now
Loading

Signing-in 3 seconds...

Signing-up 3 seconds...